Outcomes Study

Related by string. * OUTCOME . OUTCOMES . outcomes . outcome : Improving Patient Outcomes . Predicted Outcome . Main Outcome Measures . Patient Centered Outcomes . measurable outcomes . Similar Outcome . Clinical Outcomes / studying . Studying . STUDY . studys . STUDYING . study . stu dy : Pre Feasibility Study . Case Study . Study Shows . dose escalation study . Study Reveals . Study Confirms * *

Related by context. Frequent words. (Click for all words.) 65 subscales 63 HRQOL 61 Main Outcome Measures 60 HRQoL 60 QoL 59 Questionnaire 59 Depression Rating Scale 58 Montgomery Asberg Depression 57 WOMAC 57 PANSS 56 Rating Scale 55 symptom severity 55 Global Impression 55 Postoperative 55 multivariate analyzes 55 Alzheimer Disease Assessment 55 erythrocyte sedimentation rate 54 Secondary endpoints included 54 Correlates 54 Depression Inventory 54 ADAS cog 53 Negative Syndrome 53 Venous Thromboembolism 52 Longitudinal 52 MMSE 52 IIEF 52 Disease Activity 52 METHODS 51 Prognostic 51 Depressive symptoms 51 Bioavailability 51 Systematic Review 51 QOL 51 prospective observational 51 Meta Analysis 51 Cost Effectiveness 51 Psoriasis Area 51 Patient Satisfaction 51 retrospective cohort study 51 polysomnography 51 Symptom 50 subtests 50 Unified Parkinson Disease 50 MADRS 50 Secondary endpoints include 50 clinically meaningful improvement 50 Elderly Patients 50 Pathologic 50 liver transplant recipients 49 Pharmacokinetic 49 T2DM 49 Secondary endpoints 49 covariate 49 histopathologic 49 prospectively defined 49 ANOVA 49 Thrombolysis 49 prospective cohort 49 Predictors 49 symptomatology 49 comorbidity 49 Multicenter 49 affective disorders 48 univariate analysis 48 Determinants 48 Scale 48 analgesic efficacy 48 biochemical recurrence 48 Body Composition 48 Mini Mental 48 Gastric Cancer 48 preoperatively 48 somatic symptoms 48 CAVEATS 48 comorbid conditions 48 longitudinal study 47 Cardiovascular Risk 47 SYNTAX 47 Stroke Risk 47 Conclusions 47 #:#-# [037] 47 Radiation Exposure 47 PsA 47 Patient Registry 47 secondary endpoint 47 C Reactive Protein 47 Diabetic Retinopathy 47 Quantification 47 oral glucose tolerance 47 pharmacokinetics PK 47 IPSS 47 anthropometric 47 Neuropsychological 47 Natural Catastrophe Stress 47 metabolic parameters 47 liver biopsies 46 substudy 46 Benign Prostatic Hyperplasia 46 immunohistochemical 46 CONCLUSIONS 46 Evaluation

Back to home page